The Service Line

Starting January 1, 2027, the billing code that primary care practices spent two years integrating into every complex office visit will not exist. CMS released the CY2027 Medicare Physician Fee Schedule (MPFS) final rule on November 4, retiring G2211 as a standalone add-on and replacing it with two new modifiers that for the first time build the accountable care organization (ACO) premium directly into the evaluation and management (E/M) rate. Modifier B1, available to eligible clinicians providing longitudinal primary care, adds 16 percent to the payment on the associated E/M code. Modifier B2, available only to clinicians participating in a Medicare Shared Savings Program (MSSP) ACO or as participant providers in a Long-term Enhanced ACO Design (LEAD) Model ACO, adds 32 percent. The rule also finalizes conversion factors of $32.95 for qualifying alternative payment model (APM) participants and $32.63 for all others, cuts deeper than the proposed rule but maintaining a gap that makes staying inside a CMS model the clearest financial argument CMS has yet produced in writing. ACO REACH ends December 31, 2026, and LEAD Performance Year 1 begins January 1, 2027. Every primary care practice that has not yet decided whether to operate inside or outside an ACO is making that decision with a 16-percentage-point payment differential on the table. Confidence: High on the modifier structure and conversion factors, both stated in the CMS fact sheet; Medium on 53-day forward-looking framing. Sources: CY 2027 Medicare Physician Fee Schedule Final Rule, CMS, Goodbye G2211, hello B1 and B2: what the 2027 fee schedule means for primary care, Medical Economics, 2027 PFS Final Rule: ACO Impact, Arcadia.

Reimbursement: ACOs have six days to change tracks before the window closes

ACO MSSP election window, November 12-17, noon ET. ACOs that applied for a January 1, 2027 MSSP agreement period start date have a Phase 2 re-selection window opening November 12 through November 17 at noon ET to revise their BASIC vs. ENHANCED track election, now that the final rule’s B2 modifier math is on the table. CMS explicitly opened this window because the final rule, which reshapes the payment incentive for being inside MSSP vs. outside it, was published only two months before the agreement period begins. The ENHANCED track carries higher upside savings rates and commensurate downside risk; the BASIC track is a one-sided risk entry point. Under the final rule, B2 claims submitted with MSSP and LEAD modifier codes will be included in beneficiary assignment calculations, historical benchmark expenditures, and performance year expenditures for both programs, so track selection now also affects the benchmark population that determines future savings. Sources: CY 2027 MPFS Final Rule, MSSP Fact Sheet, CMS, CY 2027 MSSP and QPP Summary, American Urological Association. Confidence: High.

Enforcement: Fifth Circuit judges appeared ready to toss the RADV rule again

UPDATE on the Medicare Advantage audit extrapolation case covered August 31. A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on October 5 in the government’s appeal of the September 2025 district court ruling that vacated CMS’s 2023 risk adjustment data validation (RADV) extrapolation rule. Law360 and STAT News both reported the panel showed significant skepticism of the government’s position, with judges questioning whether CMS gave stakeholders adequate notice and opportunity to comment under the Administrative Procedure Act. No ruling has been issued as of this publication. CMS has not paused the underlying audits: it launched payment year 2020 audits in March 2026 on a quarterly cadence targeting all 550-plus RADV-eligible Medicare Advantage contracts, with PY2025 audits slated to begin April 2027. If the Fifth Circuit affirms the district court and the extrapolation rule falls a second time, hundred-million-dollar recoupment projections revert to per-contract, per-audit-sample findings. For primary care groups and ACO enablers carrying Medicare Advantage risk, the gap between “audit underway” and “extrapolated recoupment collectible” remains unresolved and legally fragile. Confidence: Medium, panel skepticism is reported by multiple outlets from oral arguments; ruling not yet issued. Sources: Judges skewer HHS arguments at RADV hearing, STAT News, 5th Circ. hints CMS Medicare Advantage rule may violate APA, Law360, Medicare Advantage Under Continued Scrutiny, American Bar Association Health Law Section.

Who’s Buying: Privia picks up 36,000 attributed lives from Cano Health’s bankruptcy at $36 million

Privia Health announced November 2 that it has agreed to acquire the MSSP attributed-lives book of American Choice Healthcare, a wholly-owned subsidiary of Cano Health, which exited Chapter 11 bankruptcy in 2025, for approximately $36 million in cash. American Choice Healthcare’s more than 36,000 attributed MSSP lives transfer to Privia’s care management platform, Privia Care Partners, effective January 1, 2027, expanding the company’s value-based care footprint into three new states. Chief executive officer Parth Mehrotra described the transaction as an attractive multiple acquired out of Cano’s bankruptcy process. It is Privia’s second acquisition of an ACO-only business in a year, following its purchase of Evolent Health’s ACO operations in January 2026, and suggests a deliberate playbook: buy attributed-life books with known benchmark histories at distressed prices and layer them onto an existing care management infrastructure. Separately, Aledade announced acquisition of the Michigan-based ACO and physician organization of CCA Holding Company, adding Southeast Michigan attribution to what is already the country’s largest independent MSSP enabler. For the broader platform picture: agilon health reported Q3 2026 revenue of $1.52 billion, up 6 percent year-over-year, with net income of $35 million against a net loss of $110 million in Q3 2025 and a medical services expense ratio that fell from 104.0 percent to 88.5 percent, a 15-point improvement that suggests the company has resolved the medical loss ratio crisis it disclosed in 2024. Sources: Privia Health Expands VBC Footprint with Acquisition of American Choice Healthcare MSSP Business, GlobeNewswire, Aledade Acquires Michigan Value-Based Care Operations, Aledade, Agilon Health Q3 2026 Earnings Press Release, SEC 8-K. Confidence: High on Privia deal price and attributed-lives count; Medium on agilon forward guidance; Medium on Aledade deal terms (not disclosed).

Clinical Policy: 16 minutes per visit is what ambient scribes return to primary care, and ACOs are starting to count it

Published research from multiple academic medical centers has quantified what ambient artificial intelligence documentation tools return to primary care clinicians: a reduction of approximately 16 minutes in documentation time per encounter, meaningful decreases in after-hours charting, and physician burnout rates that dropped from roughly 52 percent to 39 percent within 30 days of deployment, based on prospective studies at named institutions. For ACOs and medical groups operating under value-based contracts, 16 minutes per encounter is not just a quality-of-life number. Applied across a primary care physician seeing 15 patients a day, it represents roughly 4 hours of recovered clinical or administrative time per week, translating to additional patient slots, more chronic-condition coding visits, or more Advanced Primary Care Management (APCM) or Chronic Care Management (CCM) touch-points that directly affect quality scores, risk-adjustment capture, and attribution stability. The frontier question for primary care ACO operators is whether per-physician recovered time will join risk-adjustment capture rates as a managed operational variable. The research base is now strong enough that some are treating it that way. Confidence: Medium, the 16-minute and burnout figures are from peer-reviewed clinical studies at named institutions; the ACO operational read-across is this newsletter’s analysis. Sources: Ambient AI scribes reduce clinician documentation time by 16 minutes per encounter, 2 Minute Medicine, Ambient AI Redefines Clinical Productivity at Scale, PYMNTS Healthcare.

The Operator Metric: $14 per 99214 visit is now the annual cost of staying outside an ACO

The CY2027 final rule’s B2 modifier translates to roughly $28 of additional revenue per standard established-patient office visit (CPT 99214) for any primary care physician inside MSSP or LEAD, based on that code’s approximately $89 reimbursement at CY2027 rates multiplied by the 32 percent B2 add-on. B1 adds 16 percent, or roughly $14, for other eligible clinicians providing longitudinal primary care outside an ACO framework. The gap between them, $14 per qualifying 99214 visit, represents the pure modifier differential between being inside or outside a CMS model next year. For a physician seeing 15 patients a day, 250 days a year, with two-thirds of visits qualifying at the 99214 level, the annual B2-vs.-B1 differential is approximately $35,000 in Medicare revenue, before any shared-savings distribution, before risk-adjustment performance, and before the benchmark effects of B2 claims now flowing into attribution and expenditure calculations. This number will be the dominant argument in every ACO recruitment and physician retention conversation that starts January 1. Source: CY 2027 Medicare Physician Fee Schedule Final Rule, CMS. Confidence: Medium, the $89 base rate and resulting dollar figures are approximations based on current 99214 reimbursement and CY2027 proposed rates; the B2 percentage add-on is CMS-confirmed.